The Nifty Pharma has 20 companies; the largest by market value on 22 Nov 2026 was Sun Pharma.Inds..
| # | Company | Sector | Market cap | P/E | 1-year return |
|---|---|---|---|---|---|
| 1 | Sun Pharma.Inds. | Healthcare | ₹4,52,251 Cr | 36.8 | +6.0% |
| 2 | Divi's Lab. | Healthcare | ₹2,96,807 Cr | 86.9 | +73.0% |
| 3 | Torrent Pharma. | Healthcare | ₹1,78,374 Cr | 82.2 | +26.0% |
| 4 | Laurus Labs | Healthcare | ₹1,23,980 Cr | 92.5 | +132.5% |
| 5 | Zydus Lifesci. | Healthcare | ₹1,19,700 Cr | 26.4 | +29.3% |
| 6 | Dr Reddy's Labs | Healthcare | ₹1,16,119 Cr | 41.5 | +11.3% |
| 7 | Cipla | Healthcare | ₹1,14,316 Cr | 36.8 | -7.5% |
| 8 | Mankind Pharma | Healthcare | ₹1,10,077 Cr | 47.2 | +19.0% |
| 9 | Aurobindo Pharma | Healthcare | ₹1,03,510 Cr | 25.5 | +49.0% |
| 10 | Lupin | Healthcare | ₹92,099 Cr | 16.4 | -0.8% |
| 11 | Glenmark Pharma. | Healthcare | ₹74,733 Cr | 36.9 | +41.0% |
| 12 | Alkem Lab | Healthcare | ₹61,994 Cr | 28.7 | -9.0% |
| 13 | Biocon | Healthcare | ₹59,386 Cr | 87.2 | -7.8% |
| 14 | Abbott India | Healthcare | ₹56,366 Cr | 34.1 | -10.3% |
| 15 | Gland Pharma | Healthcare | ₹54,980 Cr | 43.9 | +83.3% |
| 16 | Ipca Labs. | Healthcare | ₹46,778 Cr | 32.5 | +28.2% |
| 17 | Ajanta Pharma | Healthcare | ₹41,458 Cr | 32.8 | +32.1% |
| 18 | Sai Life | Healthcare | ₹38,279 Cr | 100.2 | +106.0% |
| 19 | Wockhardt | Healthcare | ₹35,499 Cr | 88.8 | +64.8% |
| 20 | Piramal Pharma | Healthcare | ₹31,859 Cr | +26.2% |
The member list is NSE's published list for the Nifty Pharma. Companies are ordered by market value (market capitalisation), which approximates but is not the index's free-float weight. Prices and returns are from NSE and BSE closing prices as of 22 Nov 2026.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.